BackOSE Immunotherapeutics S.A. Overview

OSE Immunotherapeutics S.A. Current Cash

Track OSE Immunotherapeutics S.A.'s current cash ($18M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$17.55M
↑ 4.83% YoYΔ $809000.00 vs prior year quarter

Peer trimmed avg / median

Loading

OSE Immunotherapeutics S.A. Current Cash History

Loading

OSE Immunotherapeutics S.A. vs. peers: Current Cash Comparison

Loading

OSE Immunotherapeutics S.A. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

OSE Immunotherapeutics S.A. (ORPOF) FAQ

As of the most recent data (December 2025), ORPOF shows a current cash of $18M. That compares with $17M in the prior-year period — up 4.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPOF's current cash is now $18M (was $17M) — a 4.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether OSE Immunotherapeutics S.A. is outperforming or lagging.

Tracking ORPOF's current cash over time shows whether OSE Immunotherapeutics S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $17M in the prior-year period — up 4.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has OSE Immunotherapeutics S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $18M) with ownership activity and broader fundamentals.

OSE Immunotherapeutics S.A.'s current cash is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.